CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 14 enrolled
Drug / intervention
Chlorthalidonedrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01750294
NCT01750294Phase 4Completed
CompareCT.gov

A Pilot Study of Chlorthalidone Among Patients With Poorly Controlled Hypertension and CKD

Indiana University·interventional·Posted Dec 17, 2012·Updated Jun 13, 2016

In Brief

A Phase 4 clinical trial evaluating Chlorthalidone for Chronic Kidney Disease and Poorly-Controlled Hypertension. Completed, enrolled 14 participants across 1 site.

Detailed Summary

It is estimated that in the United States there are approximately 8 million individuals with moderate to severe chronic kidney disease (CKD), not on dialysis. Volume expansion plays an important role in the pathogenesis of hypertension in patients with CKD. For this pilot study, the investigators hypothesize that administration of chlorthalidone among patients with moderate to severe CKD will improve blood pressure (BP).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsChronic Kidney Disease, Poorly-Controlled Hypertension
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedDec 17, 2012
Enrollment StartAug 1, 2012
Primary CompletionAug 1, 2013
TodayJul 2, 2026
Enrollment to primary: 1 yearPosted 13.5 years ago

Interventions

Chlorthalidonedrug